3 Einträge gefunden

1. Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA

   1. Facon, Thierry
   2. Cook, Gordon
   3. Usmani, Saad Z
   4. Hulin, Cyrille
   5. Kumar, Shaji
   6. Plesner, Torben
   7. Touzeau, Cyrille

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy

   1. Quach, Hang
   2. Nooka, Ajay
   3. Samoylova, Olga
   4. Venner, Christopher P
   5. Kim, Kihyun
   6. Facon, Thierry
   7. Spencer, Andrew

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial

   1. Perrot, Aurore
   2. Facon, Thierry
   3. Plesner, Torben
   4. Usmani, Saad Z
   5. Kumar, Shaji
   6. Bahlis, Nizar J
   7. Hulin, Cyrille

   2021 - Forschungsinformationssystem des UKE - frei zugänglich